More on ADAG

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.8 Score)

Upcoming Events

- Earnings (8/27/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Adagene Inc. (NQ:ADAG)
Delayed: 2.84 -0.18 (5.96%)
Prev. Close $3.02  
Open$3.03 
52 Wk High$ 
52 Wk Low$ 
Day High$3.10 
Day Low$2.83 
P/E N/A  
EPS$ 
Volume10,231 

Friends, Peers and Foes (?): SNY (more...)

Feb 17, 2026 04:33 PM Form SCHEDULE 13G/A Adagene Inc. Filed by: GENERAL ATLANTIC, L.P.
Feb 17, 2026 09:27 AM Adagene to Participate in Two Upcoming Investor Conferences
Feb 2, 2026 10:00 AM ACROBiosystems Powers Innovation at bioSeedin's JPM Spotlight, Strategically Supporting Global Partnership Forging
Jan 29, 2026 04:17 PM Form SCHEDULE 13G/A Adagene Inc. Filed by: Smith Vincent C
Jan 23, 2026 08:00 AM Form 6-K Adagene Inc. For: Jan 23
Jan 23, 2026 08:00 AM Adagene Provides Business Update and 2026 Objectives
Jan 12, 2026 11:31 AM Form EFFECT Adagene Inc.
Jan 9, 2026 04:34 PM Form 424B3 Adagene Inc.
Dec 16, 2025 07:00 AM Adagene receives FDA fast track status for cancer drug muzastotug
Dec 16, 2025 07:00 AM Adagene Announces FDA Fast Track Designation for Muzastotug (ADG126)
View All Articles

Entities mentioned with ADAG

View All Entities